BioMarin Pharma (BMRN) Tops Q2 EPS by 25c
Tweet
Share
E-mail
Get Alerts BMRN Hot Sheet
Price: $66.64 -1.07%
Financial Fact:
Weighted average common shares outstanding, diluted: 167.71M
Today's EPS Names:
MSGM, SMID, VISL, More
Financial Fact:
Weighted average common shares outstanding, diluted: 167.71M
Today's EPS Names:
MSGM, SMID, VISL, More
Join SI Premium – FREE
BioMarin Pharma (NASDAQ: BMRN) reported Q2 EPS of $1.20, $0.25 better than the analyst estimate of $0.95. Revenue for the quarter came in at $990 million versus the consensus estimate of $939.37 million.
For earnings history and earnings-related data on BioMarin Pharma (BMRN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla to launch Cybercab in Austin this month - report
- Datavault AI to acquire CyberCatch for $94.5M in all-cash deal
- BioMarin Pharmaceutical Inc. (BMRN) PT Raised to $111 at Barclays
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
